Tracing Of Real-time glu13Cose Metabolism in Human Immune Cells
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorVanderbilt University Medical Center
About this trial
The purpose of this study is to understand how cells of the immune system use the common sugar glucose to fuel energy production and as a building block within the cell. Investigators will intravenously infuse a non-radioactive glucose tracer into participants over a few hours and collect immune cells from the blood to track uptake and usage of this glucose within these immune cells.
Eligibility criteria
Qualifiers
Adults aged 18 or older
Disqualifiers
Pregnant
Prisoner or in police custody
Uncontrolled hyperglycemia/diabetes
Current participation in another study where the total volume of blood drawn, when added to this study blood draw volume, exceeds 500cc in an 8 week period
Trial design
Treatments tested in this trial
- 13C6-Glucose
Treatment groups
12 Participants
are divided into 1 treatment groupLocations
1Vanderbilt University Medical Center37212, NashvilleTennessee, United States
Sponsors and collaborators
Vanderbilt University Medical Center
Lead sponsor
Source ClinicalTrials.gov